Biologicals and biosimilars, what
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: DECLERCK, Paul J (KU Leuven, Pharmaceutical and Pharmacological Sciences, Leuven, Belgium)
Biosimilars are copies of approved biopharmaceuticals for which the patent has expired.The concept of biosimilars has been introduced in the world of biopharmaceuticals since 2005.
Biopharmaceuticals are intrinsically characterized by a significant heterogeneity which on its turn is highly dependent on the expression system, culture conditions,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.